The Beauty Health Co (SKIN)
2.20
+0.02
(+0.92%)
USD |
NASDAQ |
May 31, 16:00
2.205
0.00 (0.00%)
After-Hours: 20:00
Beauty Health Research and Development Expense (Quarterly): 2.807M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.807M |
| December 31, 2023 | 3.046M |
| September 30, 2023 | 1.839M |
| June 30, 2023 | 2.881M |
| March 31, 2023 | 2.336M |
| December 31, 2022 | 1.446M |
| September 30, 2022 | 2.167M |
| June 30, 2022 | 2.601M |
| March 31, 2022 | 2.23M |
| Date | Value |
|---|---|
| December 31, 2021 | 1.875M |
| September 30, 2021 | 1.88M |
| June 30, 2021 | 2.988M |
| March 31, 2021 | 1.452M |
| December 31, 2020 | 0.86M |
| September 30, 2020 | 0.577M |
| June 30, 2020 | 0.597M |
| March 31, 2020 | 1.376M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.577M
Minimum
Sep 2020
3.046M
Maximum
Dec 2023
1.939M
Average
1.88M
Median
Sep 2021